PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 12216668

Bulking sludge solved?!

J Kruit·J Hulsbeek·A Visser
View original source ↗Export metadata ↓

Abstract

At present there is still no final theory explaining the bulking of activated sludge. Previous investigations showed that the sludge settling properties become better and more stable when more plug flow conditions are implemented in wastewater treatment plants for biological nutrient removal. In this research the effect of the process configuration (4 wwtp with fully biological nutrient removal) on the sludge settling properties has been investigated. The results show that a separate anoxic reactor can not avoid the presence of LCFA for the growth of M. parvicella in the anaerobic reactor. A SVI < 120 ml/g could be achieved by: of a separate anoxic reactor with plug flow conditions, introducing of a strictly anaerobic reactor (UCT-modification), implementation of an extra anoxic/aerobic reactor, maintaining a high oxygen concentration (> 1.5 mg/l) and creating a low ammonium concentration (< 1 mg/l) in the aerobic reactor.

Explore related subjects

ActinobacteriaBioreactorsNitrogenOxygenPopulation DynamicsSewageWaste Disposal, FluidJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Kruit, J Hulsbeek, A Visser. 2002. Bulking sludge solved?!. https://pubmed.ncbi.nlm.nih.gov/12216668/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Draft genome sequence data of Streptomyces antibioticus SCBA4 isolated from the Soils of Surigao del Sur, Philippines.

The draft genome of Streptomyces antibioticus SCBA4 isolated from the soils of Surigao del Sur, Philippines is reported here. S. antibioticus is a member of the phylum Actinomycetota, a diverse group of Gram positive, high G+C content bacteria well known for their production of a variety of bioactive compounds. Sequencing using the Illumina NovaSeq 6000 platform yielded a 8,616,999 bp genome across 36 contigs with 7621 coding sequences, 87 tRNA, and 1 tmRNA. Consistent with the members of the same phylum, the GC content was 71.83% and was found to contain putative gene clusters of secondary metabolites such as NRPs, terpenes and polyketides. The genome sequence has been deposited at NCBI under the accession number JBSWZT020000000.

Actinobacteria↗
PubMed2025

Genomes of 211 Actinomycete Strains from Diverse Environments.

Actinomycetes are a highly diverse group of microorganisms that have long been recognized as a valuable source of antibiotics and other bioactive metabolites. Recent advances in genome mining have revealed a wealth of previously unexplored silent secondary metabolite biosynthetic gene clusters (smBGCs) in actinomycete genomes, underscoring their untapped bioactivity potential. Here, we present the genome sequences of 211 actinomycete strains isolated from various environmental sources, generated through high-throughput sequencing. The resulting genome assemblies exhibit high completeness and accuracy, offering high-quality data for downstream analyses and biological resource exploration.

Actinobacteria↗
PubMed2003

Human cervicofacial actinomycoses: microbiological data for 1997 cases.

Actinomycoses are sporadically occurring endogenous polymicrobial inflammatory processes, in which fermentative actinomycetes of the genera Actinomyces, Propionibacterium, or Bifidobacterium act as the principal pathogens. Difficulties in diagnosing the disease in a timely and reliable fashion have led clinicians and microbiologists to grossly underestimate its medical importance. Therefore, we evaluated microbiological and selected clinical data derived from 1997 culture-positive cases of human cervicofacial actinomycoses examined in our laboratories during 1972-1999. The causative actinomycetes belonged to at least 9 different species, among which Actinomyces israelii and Actinomyces gerencseriae predominated. The well-known predisposition of male patients to acquire the disease varied with age and appeared to be especially pronounced in patients aged 20-60 years, the highest incidence being found in female patients aged 11-40 years and in male patients aged 21-50 years. The relevant procedures necessary for diagnosing human actinomycoses reliably, as well as details of their complex etiology, are discussed.

Actinobacteria↗